Daily Stocks List: Valeant Pharmaceuticals Intl Inc (NYSE:VRX), National HealthCare Corporation (NYSEMKT:NHC), Lion Biotechnologies (NASDAQ:LBIO), Weibo Corporation (NASDAQ:WB)

Colgate-Palmolive (NYSE: CL) declared a quarterly dividend of $0.39 per share, or $1.56 annualized. This is a 2.6% increase from the prior dividend of $0.38. The dividend will be payable on May 16, 2016, to stockholders of record on April 22, 2016, with an ex-dividend date of April 20, 2016.
Colgate-Palmolive Co. (NYSE:CL) shares advanced 0.37% in last trading session and ended the day at $68.23. CL Gross Margin is 58.70% and its has a return on assets of 10.60%. Colgate-Palmolive Co. (NYSE:CL) quarterly performance is 3.73%.

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) ended the last trading day at $66.15. Company weekly volatility is calculated as 7.24% and price to cash ratio as 15.90. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) showed a weekly performance of 1.94%.

Valeant Pharmaceuticals (NYSE: VRX) R&O Pharmacy, LLC (R&O) announced that they have jointly requested the Court to dismiss the litigation between them pursuant to a confidential settlement agreement that resolves all claims between them

On 10 March, National HealthCare Corporation (NYSEMKT:NHC) shares fell -1.19% and was closed at $63.36. NHC EPS growth in last 5 year was -0.10%. National HealthCare Corporation (NYSEMKT:NHC) year to date (YTD) performance is 2.69%.

National HealthCare Corporation (NYSE MKT: NHC), announced that it will pay a quarterly dividend of 40 cents per common share to shareholders of record on March 31, 2016 and payable on June 1, 2016.

Lion Biotechnologies, Inc. (NASDAQ:LBIO) shares fell -7.12% in last trading session and ended the day at $4.96. LBIO has a return on assets of -30.40%. Lion Biotechnologies, Inc. (NASDAQ:LBIO) quarterly performance is -38.08%.

Lion Biotechnologies, Inc. (NASDAQ:LBIO), reported year-end and fourth-quarter financial results. For the fourth quarter and year ended December 31, 2015, the company reported research and development expenses of $5.1 million and $15.5 million, respectively, compared to $2.7 million and $3.8 million, respectively, for the prior year ended December 31, 2014. General and administrative expenses totaled $3.9 million and $12.4 million, respectively, for the three months and year ended December 31, 2015, compared to $2.0 million and $8.2 million, respectively, for the same periods in 2014.

Weibo Corporation (NASDAQ:WB) caters to the Technology space. It has a net profit margin of 4.70% and weekly performance is 11.24%. On the last day of trading company shares ended up at $17.72.

On 2 March, Weibo Corporation (NASDAQ:WB) reported Net revenues increased 42% year over year to $149.0 million, reaching the high end of the Company’s guidance between $146 million and $149 million. Advertising and marketing revenue increased 47% year over year to $129.5 million. Weibo Value-Added Services (“Weibo VAS”) revenue increased 13% year over year to $19.5 million, despite a 31% year-over-year decline in revenue from data licensing, a deemphasized business.